Immunocore Holdings PLC (IMCR) is now in the Undervalued zone, suggesting that its current forward PS ratio of 3.84 is considered Undervalued compared with the five-year average of -46.29. The fair price of Immunocore Holdings PLC (IMCR) is between 44.86 to 48.67 according to relative valuation method. Compared to the current price of 32.36 USD , Immunocore Holdings PLC By Undervalued By 27.86%.

Relative Value

Fair Zone

44.86-48.67

Current Price：32.36

27.86%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Immunocore Holdings PLC (IMCR) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Immunocore Holdings PLC (IMCR) has a current Price-to-Book (P/B) ratio of 4.30. Compared to its 3-year average P/B ratio of 6.07, the current P/B ratio is approximately -29.21% higher. Relative to its 5-year average P/B ratio of 6.22, the current P/B ratio is about -30.90% higher. Immunocore Holdings PLC (IMCR) has a Forward Free Cash Flow (FCF) yield of approximately 0.17%. Compared to its 3-year average FCF yield of 0.49%, the current FCF yield is approximately -64.49% lower. Relative to its 5-year average FCF yield of -2.49%, the current FCF yield is about -106.94% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for IMCR competitors is 10.00, providing a benchmark for relative valuation. Immunocore Holdings PLC Corp (IMCR.O) exhibits a P/S ratio of 3.84, which is -61.59% above the industry average. Given its robust revenue growth of 24.30%, this premium appears sustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of IMCR increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of IMCR in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is IMCR currently overvalued or undervalued?

Immunocore Holdings PLC (IMCR) is now in the Undervalued zone, suggesting that its current forward PS ratio of 3.84 is considered Undervalued compared with the five-year average of -46.29. The fair price of Immunocore Holdings PLC (IMCR) is between 44.86 to 48.67 according to relative valuation method. Compared to the current price of 32.36 USD, Immunocore Holdings PLC is Undervalued By 27.86%.

What is Immunocore Holdings PLC (IMCR) fair value?

IMCR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Immunocore Holdings PLC (IMCR) is between 44.86 to 48.67 according to relative valuation method.

How does IMCR's valuation metrics compare to the industry average?

The average P/S ratio for IMCR's competitors is 10.00, providing a benchmark for relative valuation. Immunocore Holdings PLC Corp (IMCR) exhibits a P/S ratio of 3.84, which is -61.59% above the industry average. Given its robust revenue growth of 24.30%, this premium appears sustainable.

What is the current P/B ratio for Immunocore Holdings PLC (IMCR) as of Mar 04 2026?

As of Mar 04 2026, Immunocore Holdings PLC (IMCR) has a P/B ratio of 4.30. This indicates that the market values IMCR at 4.30 times its book value.

What is the current FCF Yield for Immunocore Holdings PLC (IMCR) as of Mar 04 2026?

As of Mar 04 2026, Immunocore Holdings PLC (IMCR) has a FCF Yield of 0.17%. This means that for every dollar of Immunocore Holdings PLC's market capitalization, the company generates 0.17 cents in free cash flow.

What is the current Forward P/E ratio for Immunocore Holdings PLC (IMCR) as of Mar 04 2026?

As of Mar 04 2026, Immunocore Holdings PLC (IMCR) has a Forward P/E ratio of -69.00. This means the market is willing to pay $-69.00 for every dollar of Immunocore Holdings PLC's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Immunocore Holdings PLC (IMCR) as of Mar 04 2026?

As of Mar 04 2026, Immunocore Holdings PLC (IMCR) has a Forward P/S ratio of 3.84. This means the market is valuing IMCR at $3.84 for every dollar of expected revenue over the next 12 months.

IMCR Valuation